In 2007 Maryland’s cervical cancer policy changed with HB 1049/SB 774, Task Force on the HPV Vaccine, which made Merck’s Gardasil vaccine the new centerpiece—the proven test and educate strategy was abandoned. Since then Maryland’s cervical cancer incidence is up 8%.